Volunteer-led behavioural activation to reduce depression in residential care: a feasibility study

Pilot and Feasibility Studies
Christina BryantBriony Dow

Abstract

Symptoms of depression are highly prevalent and under-treated in residential aged care facilities. Behavioural activation is a simple, cost-effective psychosocial intervention that might be appropriate to help reduce depression and improve well-being in this setting. The purpose of this study was to investigate the feasibility and efficacy of an 8-week, volunteer-led behavioural activation intervention designed for depressed aged care residents. This feasibility study employed a single-arm design, where outcomes were measured at baseline, post-intervention and 3-month follow-up. Aged care residents with depressive symptoms were invited to participate, and healthy volunteers were trained to deliver the intervention. Intervention feasibility was assessed on six a priori-determined domains. Depression, anxiety and flourishing were included as outcomes using intention-to-treat analysis. Seventeen aged care residents with depressive symptoms and 13 volunteers were successfully recruited within the expected 6-month timeframe. Both residents and volunteers were satisfied with the intervention (7/8), and there was a high (87%) completion rate. The intervention was associated with a large and statistically significant reduction in resid...Continue Reading

References

Dec 10, 1999·Applied Nursing Research : ANR·C McCurrenS Looney
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
May 6, 2003·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Nancy Morrow-HowellFengyan Tang
Feb 26, 2004·Journal of Personality Assessment·Stephanie BauerSteven Lars Nielsen
Nov 24, 2004·Journal of Affective Disorders·K JongenelisM W Ribbe
Apr 12, 2005·International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services·Judith DonoghueJulie Gibbs
Sep 24, 2005·Journal of Health Psychology·Alex H S Harris, Carl E Thoresen
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
May 17, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Caroline SutcliffePeter Huxley
Aug 21, 2008·Health and Quality of Life Outcomes·Natalie A de MortonJennifer L Keating
Sep 3, 2010·BMC Family Practice·Elizabeth PhelanMark Snowden
Feb 5, 2011·Behavior Therapy·Melissa SnarskiJacquelyn Marcinak
Mar 25, 2011·International Psychogeriatrics·Briony DowDavid Ames
Oct 28, 2011·Clinical and Translational Science·Charity G MoorePaul W Stewart
Aug 14, 2012·Journal of Affective Disorders·Isabelle Soucy Chartier, Martin D Provencher
May 15, 2013·General Hospital Psychiatry·Rüya-Daniela KocaleventElmar Brähler
Jun 19, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Beate WildBernd Löwe
Apr 9, 2014·Health Affairs·Sheryl ZimmermanDavid Reed
Jun 29, 2014·Maturitas·Pim CuijpersCharles F Reynolds
Apr 1, 2013·The Behavior Analyst·Courtney Allyn Polenick, Stephen Ray Flora
Apr 14, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jin Hui JooJoseph J Gallo
Oct 21, 2016·International Psychogeriatrics·Adam Simning, Kelsey V Simons
May 26, 2017·International Journal of Geriatric Psychiatry·Christine M UlbrichtKate L Lapane
Oct 7, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Vasiliki OrgetaGill Livingston

❮ Previous
Next ❯

Software Mentioned

GPower

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.